Clinical Trials Browser

Phase 1 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × tipifarnib × Clear all

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00022451 2012-03-15

Tipifarnib in Treating Young Patients With Refractory Leukemia

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia

Tipifarnib in Treating Young Patients With Refractory Leukemia